Home - Products - Autophagy - CXCR - FC131 TFA (606968-52-9 free base)

FC131 TFA (606968-52-9 free base)

CAS No. ——

FC131 TFA (606968-52-9 free base)( —— )

Catalog No. M30047 CAS No. ——

FC131 TFA is a CXCR4 antagonist that inhibits the binding of [125I] -sdf-1 to CXCR4 with an IC50 value of 4.5 nM and has anti-hiv activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 122 Get Quote
5MG 260 Get Quote
10MG 437 Get Quote
25MG 716 Get Quote
50MG 1017 Get Quote
100MG 1422 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote

Biological Information

  • Product Name
    FC131 TFA (606968-52-9 free base)
  • Note
    Research use only, not for human use.
  • Brief Description
    FC131 TFA is a CXCR4 antagonist that inhibits the binding of [125I] -sdf-1 to CXCR4 with an IC50 value of 4.5 nM and has anti-hiv activity.
  • Description
    FC131 TFA is a CXCR4 antagonist that inhibits the binding of [125I] -sdf-1 to CXCR4 with an IC50 value of 4.5 nM and has anti-hiv activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Autophagy
  • Target
    CXCR
  • Recptor
    IC50: 4.5 nM ([125I]-SDF-1-CXCR4)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    843.85
  • Molecular Formula
    C38H48F3N11O8
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 250 mg/mL (296.26 mM; Need ultrasonic)
  • SMILES
    ——
  • Chemical Name
    Sequence:{2-Naph-Ala}-{Gly}-{Tyr}-{Arg}-{Arg}

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Tamamura H, et al. Stereoselective synthesis of [L-Arg-L/D-3-(2-naphthyl)alanine]-type (E)-alkene dipeptide isosteres and its application to the synthesis and biological evaluation of pseudopeptide analogues of the CXCR4 antagonist FC131. J Med Chem. 2005 Jan 27;48(2):380-91.
molnova catalog
related products
  • Eldelumab

    Eldelumab (BMS-936557) is a humanized anti-IP-10 IgG type 1 monoclonal antibody with inhibitory activity against CXCL10. It has anti-inflammatory properties, selectively binds to CXCL10, and can be used in the study of rheumatoid arthritis, ulcerative colitis, and Crohn's disease.

  • SX-682

    SX-682 is a potent, selective and orally bioavailable inhibitor of CXCR1/2 ,has the potential to treat castration-resistant prostate cancer.

  • FC131 TFA

    FC131 TFA is an antagonist of CXCR4 that inhibits the binding of [125I] -sdf-1 to CXCR4(IC50 : 4.5 nM ), and has anti-hiv activity.